Calculus Bovis Market: Size, Share, Growth, Analysis, Key Players, Revenue, Growth | Valuates Reports

Global Calculus Bovis Market
The global Calculus Bovis market was valued at US$ 131.7 million in 2022 and is anticipated to reach US$ 342.2 million by 2029, witnessing a CAGR of 16.0% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-12C14051/Global_Calculus_Bovis_Market_Research_Report_2023

The global key manufacturers of calculus bovis include Jianmin Group, Dibo Pharmaceuticals, Mingxing Pharmaceuticals, Renqi Pharmaceuticals, Hongmao Pharmaceuticals, and Tongrentang. The top five manufacturers together account for 80% of the market share, with Jianmin Group being the largest producer with 20% of the market share. The global origin is mainly concentrated in China. At the consumer level, China holds close to 90% of the market share. In terms of product category, it is divided into in vitro calculus bovis and artificial bezoar, with the former having a higher market share of 75%. In terms of its application,preparations medicine is its top application area with 95% market share, followed by Chinese hebal medicine.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Calculus Bovis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Calculus Bovis.
The Calculus Bovis market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Calculus Bovis market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Calculus Bovis manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

Get regional report
https://reports.valuates.com/request/regional/QYRE-Auto-12C14051/Global_Calculus_Bovis_Market_Research_Report_2023

Key Segmentations
By Company
• Jianmin Group
• Dibo Pharmaceuticals
• Ming Hing Pharmaceutical
• Renqi Pharmaceutical
• Hongmao Pharmaceutical
• Tongrentang
Segment by Type
• Artificial Bezoar
• In Vitro Cultured Bezoar
Segment by Application
• Preparations Medicine
• Chinese Herbal Medicine

View full report
https://reports.valuates.com/market-reports/QYRE-Auto-12C14051/global-calculus-bovis

Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066,

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.